BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 31606241)

  • 1. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.
    Xia T; Wu X; Cao M; Zhang P; Shi G; Zhang J; Lu Z; Wu P; Cai B; Miao Y; Jiang K
    Pathol Res Pract; 2019 Nov; 215(11):152666. PubMed ID: 31606241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
    Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
    Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.
    Chen J; Zhang H; Xiu C; Gao C; Wu S; Bai J; Shen Q; Yin T
    Cancer Lett; 2023 Jul; 565():216222. PubMed ID: 37196908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability.
    Xu Y; Bao Y; Qiu G; Ye H; He M; Wei X
    Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
    Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
    Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 promotes the growth and metastasis of pancreatic cancer by regulating the m6A modification and stability of E2F5.
    Tang Y; Gao G; Xia WW; Wang JB
    Cell Signal; 2022 Nov; 99():110440. PubMed ID: 35985439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.
    He Y; Hu H; Wang Y; Yuan H; Lu Z; Wu P; Liu D; Tian L; Yin J; Jiang K; Miao Y
    Cell Physiol Biochem; 2018; 48(2):838-846. PubMed ID: 30032148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB.
    Wanna-Udom S; Terashima M; Lyu H; Ishimura A; Takino T; Sakari M; Tsukahara T; Suzuki T
    Biochem Biophys Res Commun; 2020 Mar; 524(1):150-155. PubMed ID: 31982139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2.
    Dahal U; Le K; Gupta M
    Melanoma Res; 2019 Aug; 29(4):382-389. PubMed ID: 30762711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
    Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
    J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA m
    Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
    J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
    Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
    Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.